NTLA logo

Intellia Therapeutics (NTLA) Operating profit

annual operating profit:

-$534.26M-$18.97M(-3.68%)
December 31, 2024

Summary

  • As of today (June 22, 2025), NTLA annual operating income is -$534.26 million, with the most recent change of -$18.97 million (-3.68%) on December 31, 2024.
  • During the last 3 years, NTLA annual operating profit has fallen by -$266.41 million (-99.46%).
  • NTLA annual operating profit is now -3884.36% below its all-time high of -$13.41 million, reached on December 31, 2015.

Performance

NTLA Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAincome statement metrics

quarterly operating profit:

-$120.81M+$15.64M(+11.46%)
March 31, 2025

Summary

  • As of today (June 22, 2025), NTLA quarterly operating income is -$120.81 million, with the most recent change of +$15.64 million (+11.46%) on March 31, 2025.
  • Over the past year, NTLA quarterly operating profit has dropped by -$6.80 million (-5.97%).
  • NTLA quarterly operating profit is now -10009.37% below its all-time high of -$1.20 million, reached on March 31, 2015.

Performance

NTLA quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAincome statement metrics

TTM operating profit:

-$541.07M-$6.80M(-1.27%)
March 31, 2025

Summary

  • As of today (June 22, 2025), NTLA TTM operating income is -$541.07 million, with the most recent change of -$6.80 million (-1.27%) on March 31, 2025.
  • Over the past year, NTLA TTM operating profit has dropped by -$23.73 million (-4.59%).
  • NTLA TTM operating profit is now -45177.57% below its all-time high of -$1.20 million, reached on March 31, 2015.

Performance

NTLA TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNTLAincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

NTLA Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.7%-6.0%-4.6%
3 y3 years-99.5%+16.3%-48.0%
5 y5 years-402.3%-265.6%-368.0%

NTLA Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-99.5%at low-22.9%+16.6%-48.0%at low
5 y5-year-402.3%at low-329.9%+16.6%-368.0%at low
alltimeall time-3884.4%at low<-9999.0%+16.6%<-9999.0%at low

NTLA Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$120.81M(-11.5%)
-$541.07M(+1.3%)
Dec 2024
-$534.26M(+3.7%)
-$136.45M(-5.7%)
-$534.26M(-0.6%)
Sep 2024
-
-$144.77M(+4.1%)
-$537.71M(+2.6%)
Jun 2024
-
-$139.04M(+22.0%)
-$524.04M(+1.3%)
Mar 2024
-
-$114.00M(-18.5%)
-$517.34M(+0.4%)
Dec 2023
-$515.29M(+12.5%)
-$139.89M(+6.7%)
-$515.29M(+6.1%)
Sep 2023
-
-$131.11M(-0.9%)
-$485.49M(+5.6%)
Jun 2023
-
-$132.33M(+18.2%)
-$459.91M(+8.0%)
Mar 2023
-
-$111.96M(+1.7%)
-$425.88M(-7.0%)
Dec 2022
-$458.16M(+71.1%)
-$110.09M(+4.3%)
-$458.16M(+6.9%)
Sep 2022
-
-$105.53M(+7.4%)
-$428.49M(+8.5%)
Jun 2022
-
-$98.30M(-31.9%)
-$394.95M(+8.0%)
Mar 2022
-
-$144.25M(+79.4%)
-$365.67M(+36.5%)
Dec 2021
-$267.85M(+96.1%)
-$80.42M(+11.7%)
-$267.85M(+16.5%)
Sep 2021
-
-$71.99M(+4.3%)
-$229.83M(+23.6%)
Jun 2021
-
-$69.02M(+48.7%)
-$185.94M(+24.0%)
Mar 2021
-
-$46.42M(+9.5%)
-$149.96M(+9.8%)
Dec 2020
-$136.58M
-$42.40M(+50.9%)
-$136.58M(+10.2%)
Sep 2020
-
-$28.10M(-14.9%)
-$123.95M(+2.3%)
Jun 2020
-
-$33.03M(-0.0%)
-$121.18M(+4.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$33.05M(+11.0%)
-$115.61M(+8.7%)
Dec 2019
-$106.37M(+17.1%)
-$29.77M(+17.5%)
-$106.37M(+9.3%)
Sep 2019
-
-$25.33M(-7.8%)
-$97.34M(+1.3%)
Jun 2019
-
-$27.46M(+15.3%)
-$96.11M(+4.2%)
Mar 2019
-
-$23.81M(+14.8%)
-$92.25M(+1.5%)
Dec 2018
-$90.87M(+30.6%)
-$20.75M(-13.9%)
-$90.87M(-4.2%)
Sep 2018
-
-$24.10M(+2.1%)
-$94.84M(+9.5%)
Jun 2018
-
-$23.59M(+5.2%)
-$86.61M(+9.6%)
Mar 2018
-
-$22.43M(-9.2%)
-$79.04M(+13.6%)
Dec 2017
-$69.56M(+116.3%)
-$24.71M(+55.7%)
-$69.56M(+25.0%)
Sep 2017
-
-$15.88M(-0.9%)
-$55.66M(+17.2%)
Jun 2017
-
-$16.02M(+23.7%)
-$47.48M(+23.6%)
Mar 2017
-
-$12.95M(+19.6%)
-$38.41M(+19.4%)
Dec 2016
-$32.16M(+139.8%)
-$10.82M(+40.6%)
-$32.16M(+19.9%)
Sep 2016
-
-$7.70M(+10.8%)
-$26.83M(+19.6%)
Jun 2016
-
-$6.95M(+3.8%)
-$22.43M(+18.6%)
Mar 2016
-
-$6.69M(+21.9%)
-$18.91M(+41.0%)
Dec 2015
-$13.41M
-$5.49M(+66.3%)
-$13.41M(+69.3%)
Sep 2015
-
-$3.30M(-3.5%)
-$7.92M(+71.5%)
Jun 2015
-
-$3.42M(+186.4%)
-$4.62M(+286.4%)
Mar 2015
-
-$1.20M
-$1.20M

FAQ

  • What is Intellia Therapeutics annual operating income?
  • What is the all time high annual operating profit for Intellia Therapeutics?
  • What is Intellia Therapeutics annual operating profit year-on-year change?
  • What is Intellia Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Intellia Therapeutics?
  • What is Intellia Therapeutics quarterly operating profit year-on-year change?
  • What is Intellia Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Intellia Therapeutics?
  • What is Intellia Therapeutics TTM operating profit year-on-year change?

What is Intellia Therapeutics annual operating income?

The current annual operating profit of NTLA is -$534.26M

What is the all time high annual operating profit for Intellia Therapeutics?

Intellia Therapeutics all-time high annual operating income is -$13.41M

What is Intellia Therapeutics annual operating profit year-on-year change?

Over the past year, NTLA annual operating income has changed by -$18.97M (-3.68%)

What is Intellia Therapeutics quarterly operating income?

The current quarterly operating profit of NTLA is -$120.81M

What is the all time high quarterly operating profit for Intellia Therapeutics?

Intellia Therapeutics all-time high quarterly operating income is -$1.20M

What is Intellia Therapeutics quarterly operating profit year-on-year change?

Over the past year, NTLA quarterly operating income has changed by -$6.80M (-5.97%)

What is Intellia Therapeutics TTM operating income?

The current TTM operating profit of NTLA is -$541.07M

What is the all time high TTM operating profit for Intellia Therapeutics?

Intellia Therapeutics all-time high TTM operating income is -$1.20M

What is Intellia Therapeutics TTM operating profit year-on-year change?

Over the past year, NTLA TTM operating income has changed by -$23.73M (-4.59%)
On this page